Oncology RFP Opportunities
Gilead Sciences offers funding for innovative oncology research, especially in solid tumors, aiming to improve clinical decision-making and patient outcomes.
Funder: Gilead Sciences
Due Dates (Anticipated): September 2026 (RFP Letter of Interest deadline, projected)
Funding Amounts: Typically $180,000 per award over 2 years; 3–4 awards per cycle expected.
Summary: Supports impactful oncology research proposals to advance clinical decision-making and patient outcomes.
Key Information: This is a forecasted opportunity; no current RFP is open—dates and details may change.
Description
Gilead Sciences' Oncology Request for Proposal (RFP) Opportunities provide funding for innovative, high-quality research projects in oncology. The program aims to support studies that can influence clinical decision-making and improve outcomes for cancer patients. Researchers are invited to submit proposals addressing unmet needs or advancing knowledge in oncology, with particular interest in solid tumors. Proposals are submitted via the Gilead OPTICS portal and typically begin with a Letter of Interest (LOI) before a full proposal is invited.
